Sangamo Biosciences, Inc. (SGMO) Reports In-Line Q3 EPS
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q3 EPS of ($0.11), in-line with the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
